Krystal Biotech, Inc. (KRYS)
309.03
-1.27
(-0.41%)
USD |
NASDAQ |
May 29, 16:00
317.00
+7.97
(+2.58%)
After-Hours: 20:00
Krystal Biotech Total Assets (Quarterly) : 1.397B for March 31, 2026
Total Assets (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Assets (Quarterly) Benchmarks
| Marker Therapeutics, Inc. | 17.43M |
| Tenaya Therapeutics, Inc. | 135.07M |
| TG Therapeutics, Inc. | 1.529B |
| Vericel Corp. | 485.63M |
| Catalyst Pharmaceuticals, Inc. | 1.148B |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 120.24M |
| Shareholders Equity (Quarterly) | 1.277B |
| Debt to Equity Ratio | 0.0071 |
| Current Ratio | 9.459 |
| Net Debt Paydown Yield | -0.00% |